Ovarian minimal residual disease in chronic myeloid leukaemia.

[1]  E. Ginsburg,et al.  Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients. , 2013, Fertility and sterility.

[2]  Jacques Donnez,et al.  Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. , 2013, Fertility and sterility.

[3]  Claus Yding Andersen,et al.  Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. , 2013, Fertility and sterility.

[4]  D. Christiansen,et al.  Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination. , 2013, European journal of cancer.

[5]  M. Andersen,et al.  Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. , 2012, Blood.

[6]  A. des Rieux,et al.  Transplantation of an alginate-matrigel matrix containing isolated ovarian cells: first step in developing a biodegradable scaffold to transplant isolated preantral follicles and ovarian cells. , 2012, Biomaterials.

[7]  R. Fodde,et al.  Cancer stem cells and metastasis. , 2012, Seminars in cancer biology.

[8]  A. Hochhaus,et al.  Chronic myeloid leukemia: clinical impact of BCR-ABL1 mutations and other lesions associated with disease progression. , 2012, Seminars in oncology.

[9]  N. Saijo.  Critical comments for roles of biomarkers in the diagnosis and treatment of cancer. , 2012, Cancer treatment reviews.

[10]  S. Silber.  Ovary cryopreservation and transplantation for fertility preservation. , 2012, Molecular human reproduction.

[11]  Martin C. Müller,et al.  BCR-ABL mutations in chronic myeloid leukemia. , 2011, Hematology/oncology clinics of North America.

[12]  M. Beckmann,et al.  Xenotransplantation of cryopreserved ovarian tissue from patients with ovarian tumors into SCID mice--no evidence of malignant cell contamination. , 2011, Fertility and sterility.

[13]  Michael W. Anderson,et al.  Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. , 2011, Fertility and sterility.

[14]  T. G. Marr,et al.  Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities , 2011, Journal of oncology.

[15]  C. Stern,et al.  Detection of Hodgkin lymphoma within ovarian tissue. , 2011, Fertility and sterility.

[16]  L. Kjeldsen,et al.  Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia. , 2010, Fertility and sterility.

[17]  P. Saussoy,et al.  Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. , 2010, Blood.

[18]  M. Feinmesser,et al.  Occasional involvement of the ovary in Ewing sarcoma. , 2010, Human reproduction.

[19]  H. Sasano,et al.  Potential indications for ovarian autotransplantation based on the analysis of 5,571 autopsy findings of females under the age of 40 in Japan. , 2010, Fertility and sterility.

[20]  J. Radich,et al.  Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Vardiman.  Chronic myelogenous leukemia, BCR-ABL1+. , 2009, American Journal of Clinical Pathology.

[22]  A. Nagler,et al.  Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. , 2008, Human reproduction.

[23]  C. Bueso-Ramos,et al.  New insights into the pathobiology and treatment of chronic myelogenous leukemia. , 2007, Annals of diagnostic pathology.

[24]  B. Fisch,et al.  In vitro maturation of human primordial ovarian follicles: clinical significance, progress in mammals, and methods for growth evaluation. , 2006, Histology and histopathology.

[25]  H. Cavé,et al.  Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program , 2003, Leukemia.

[26]  Irving L. Weissman,et al.  Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Radford,et al.  Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. , 2001, Human reproduction.

[28]  B. Druker,et al.  Chronic myelogenous leukemia , 2001, Current opinion in oncology.

[29]  L. Zon,et al.  Developmental biology of hematopoiesis. , 1995, Blood.

[30]  N. Funata,et al.  A study of leukemic cell infiltration in the testis and ovary. , 1976, The Bulletin of Tokyo Medical and Dental University.

[31]  B. Singh.  Standardization and Quality Control , 1972 .

[32]  C. Andersen,et al.  The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature , 2012, Journal of Assisted Reproduction and Genetics.

[33]  A. Sudoyo,et al.  Cytogenetics in solid tumors: lessons from the Philadelphia Chromosome. , 2011, Acta medica Indonesiana.